ATSP7041 is a hydrocarbon-stapled α-helical peptide engineered to inhibit specific protein-protein interactions. The stapling constraint stabilizes helix content and enhances proteolytic resistance. Researchers study its binding thermodynamics, cell permeability, and structural features by biophysical methods. Applications include PPI-modulation research, stapled-peptide technology development, and conformational-constraint studies.
ATSP7041 is a synthetic stapled peptide designed to modulate protein-protein interactions, particularly those involving the p53 tumor suppressor pathway. Characterized by its hydrocarbon-stapling technology, this peptide exhibits enhanced alpha-helicity, increased proteolytic stability, and improved cell permeability compared to linear analogs. These features make ATSP7041 a valuable molecular tool for probing intracellular signaling pathways, studying the dynamics of protein interactions, and advancing research in targeted therapeutic strategies. Its unique structure allows it to mimic native protein surfaces, thereby enabling selective engagement with target proteins that are often considered undruggable by traditional small molecules. As a research-grade compound, ATSP7041 serves as a versatile agent for scientists exploring the intricate mechanisms of cellular regulation and protein function.
Protein-Protein Interaction Studies: ATSP7041 is widely utilized in the investigation of protein-protein interactions, especially those involving the MDM2 and MDMX oncoproteins with p53. By competitively binding to these regulatory proteins, the peptide disrupts the inhibitory complex formed with p53, facilitating the study of p53 activation and stabilization in various cellular contexts. Researchers leverage this property to decipher the molecular consequences of p53 pathway reactivation, aiding in the identification of downstream effectors and regulatory networks. The robust binding affinity and specificity of ATSP7041 enable precise mapping of interaction domains and contribute to the development of new assays for high-throughput screening of protein interaction modulators.
Cell Signaling Pathway Analysis: The stapled peptide is instrumental in dissecting complex cell signaling pathways that govern cell cycle progression, apoptosis, and stress responses. Its ability to penetrate cell membranes and resist enzymatic degradation allows for sustained intracellular activity, providing researchers with a reliable tool to modulate signaling cascades in live cell systems. By selectively interfering with the p53-MDM2/MDMX axis, ATSP7041 facilitates the elucidation of feedback mechanisms, cross-talk with other signaling molecules, and the temporal dynamics of pathway activation. Such studies are crucial for understanding the broader impact of p53 regulation on cellular homeostasis and disease progression.
Drug Discovery and Lead Optimization: In the realm of drug discovery, ATSP7041 serves as an invaluable scaffold for the design and optimization of next-generation therapeutics targeting protein-protein interactions. Its stapled architecture offers insights into the structural requirements for effective inhibition of challenging targets, guiding medicinal chemists in the rational design of novel peptidomimetics and small-molecule inhibitors. The peptide's demonstrated efficacy in disrupting key oncogenic interactions provides a benchmark for evaluating the potency and selectivity of new compounds, accelerating the preclinical development pipeline for innovative drug candidates.
Structural Biology and Biophysical Characterization: Researchers employ ATSP7041 as a model system for structural and biophysical studies of peptide-protein complexes. Its stable, helical conformation facilitates crystallization and NMR analysis, enabling high-resolution elucidation of binding interfaces and conformational changes upon target engagement. These structural insights are instrumental in advancing our understanding of molecular recognition, allosteric regulation, and the principles governing protein surface mimicry. Additionally, the peptide's unique properties make it suitable for use in biophysical assays such as surface plasmon resonance and isothermal titration calorimetry, providing quantitative data on binding kinetics and thermodynamics.
Chemical Biology Tool Development: The utility of ATSP7041 extends to the development of chemical biology tools for interrogating cellular processes. Its modular design allows for site-specific modification with fluorophores, affinity tags, or crosslinkers, enabling real-time visualization, pull-down experiments, and proximity labeling studies. By incorporating these functional groups, researchers can monitor peptide localization, track dynamic interactions in living cells, and identify novel binding partners. Such applications are critical for expanding our toolkit for probing the proteome and unraveling the complexities of cellular regulation at the molecular level.
Peptide-based Research Platform: As the field of peptide therapeutics continues to evolve, ATSP7041 exemplifies the potential of stapled peptides as a research platform for studying protein-protein interactions and cellular signaling. Its robust performance in diverse experimental settings underscores its value in basic and translational research, fostering the development of innovative approaches to target previously intractable biological processes. By offering a reliable and adaptable molecular probe, ATSP7041 empowers scientists to advance their understanding of fundamental biology and accelerate the discovery of new therapeutic strategies.
1. Cationic cell-penetrating peptides are potent furin inhibitors
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More